Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid in Percutaneous Nephrolithotomy
NCT07582341Phase 4Completed
- Sponsor
- Benha University
- Start
- Jun 2025
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tranexamic acid (2 arms), sponsored by Benha University. Primary endpoint: Change in hemoglobin concentration after percutaneous nephrolithotomy. Started Jun 2025; status: completed.
02
Drugs
tranexamic acid
Beyond the preview
Go deeper on NCT07582341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07582341.